Cost analysis of colorectal cancer (CRC) management in UKM Medical Centre using clinical pathway

Natrah Mohd; Sharifa Ezat; Syed Mohamed Aljunid; Mohd Rizal Abdul Manaf; Saperi Sulong; Ismail Sagap; Muhd Azrif

首页> 外文期刊>BMC Public Health >Cost analysis of colorectal cancer (CRC) management in UKM Medical Centre using clinical pathway

【24h】

Cost analysis of colorectal cancer (CRC) management in UKM Medical Centre using clinical pathway

机译：UKM医疗中心使用临床途径进行结直肠癌（CRC）管理的成本分析

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《BMC Public Health》 |2012年第2期|共页
作者
Natrah Mohd; Sharifa Ezat; Syed Mohamed Aljunid; Mohd Rizal Abdul Manaf; Saperi Sulong; Ismail Sagap; Muhd Azrif;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Clinical acquired resistance to combined RAF/EGFR or RAF/MEK inhibition in BRAF mutant colorectal cancer (CRC) patients through MAPK pathway alterations [J] . Corcoran R., Coffee E. M., Van Allen E., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2014,第Suppla6期

机译：通过MAPK途径改变对BRAF突变型结直肠癌（CRC）患者进行RAF / EGFR或RAF / MEK联合抑制的临床获得性耐药
2. Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis [J] . Sethi Manveen K., Thaysen-Andersen Morten, Kim Hoguen, Journal of proteomics . 2015,第Null期

机译：对结直肠癌和非致瘤组织进行定量蛋白质组学分析，揭示了标志蛋白和参与CRC进展和转移的干扰途径
3. The benchmark analysis of gastric, colorectal and rectal cancer pathways: toward establishing standardized clinical pathway in the cancer care. [J] . Ryu M, Hamano M, Nakagawara A, Japanese journal of clinical oncology. . 2011,第1期

机译：胃癌，大肠癌和直肠癌途径的基准分析：在癌症治疗中建立标准化的临床途径。
4. Determination of EGFR and VEGF signaling pathway activity by immuno-MALDI to predict the outcome of targeted colorectal cancer (CRC) treatment [C] . Robert Popp, Andrew G. Chambers, Adriana Aguilar-Mahecha, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：免疫马尔迪的EGFR和VEGF信号通路活性预测靶向结直肠癌（CRC）治疗的结果
5. Carcinoembryonic antigen (CEA) inhibits anoikis in colorectal cancer (CRC) cells by interfering with TRAIL-R2 (DR5) signaling [D] . Samara, Raed N. 2006

机译：癌胚抗原（CEA）通过干扰TRAIL-R2（DR5）信号传导来抑制结直肠癌（CRC）细胞的失神经
6. Cost analysis of colorectal cancer (CRC) management in UKM Medical Centre using clinical pathway [O] . Natrah Mohd, Sharifa Ezat, Syed Mohamed Aljunid, 2012

机译：UKM医疗中心使用临床途径进行结直肠癌（CRC）管理的成本分析
7. Cost analysis of colorectal cancer (CRC) management in UKM Medical Centre using clinical pathway [O] . Mohd Natrah, Ezat Sharifa, Mohamed Aljunid Syed, 2012

机译：UKM医疗中心使用临床途径进行结直肠癌（CRC）管理的成本分析
8. Health Care Systems for Tracking Colorectal Cancer Screening Tests: Final Report on the System Approach to Tracking and Increasing Screening for Public Health Improvement of Colorectal Cancer (SATIS-PH/CRC) Intervention [R] . Harris, D. M., Borksy, A. E. 2010

机译：用于跟踪结肠直肠癌筛查测试的医疗保健系统：跟踪和增加结直肠癌公共卫生改善筛查系统方法的最终报告（saTIs-pH / CRC）干预

Cost analysis of colorectal cancer (CRC) management in UKM Medical Centre using clinical pathway

著录项

相似文献

相关主题

期刊订阅